Dr. Ronald T. Uszenski, MD

Dr. Uszenski practices at Iredell Memorial Hospital in Statesville, North Carolina, part of Iredell Health System.

Dr. Uszenski's NPI, 1447230099, was assigned on January 19, 2006. Dr. Uszenski holds North Carolina license 2006-00435.

Dr. Uszenski's primary practice is Iredell Memorial Hospital, at 557 Brookdale Dr, Statesville, NC 28677 in Iredell County. The practice phone is (704) 878-5661.

Dr. Uszenski's primary practice is Iredell Memorial Hospital in Statesville, North Carolina, part of Iredell Health System. Dr. Uszenski is also affiliated with Iredell Davis Behavioral Health Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Uszenski to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uszenski practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Uszenski's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Uszenski's licenses on file in 2 states: North Carolina and Tennessee.

CMS data shows 1,982 Medicare services from Dr. Uszenski across 15 procedure codes in 2024, for 774 Medicare patients. Medicare paid $108,081 for them.

CMS counts 774 Medicare patients who saw Dr. Uszenski in 2024. The largest group is 75 to 84, with 333 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Uszenski's median patient age at 75, with 48% women.

In 2024, Dr. Uszenski wrote 5,678 Medicare Part D claims for 767 patients. 81% of them were for generic drugs. CMS names the drug for 5,382 of them, across 60 drugs with 11 or more claims each, at $1,184,889 in total drug cost. In 2023, CMS named 4,250 claims across 57 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Uszenski for performance year 2024, reported through an alternative payment model (APM). Dr. Uszenski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1,064 general payments to Dr. Uszenski from 27 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. Janssen Pharmaceuticals, Inc paid the most, $811,020.